Peptide record

TPDB66391

ACE inhibitor ACE inhibitors standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB66391
ACE inhibitor
ACE inhibitors
Cardiometabolic peptides
Peptipedia
standard
No
A 13-aa standard-residue ace inhibitors peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
EQGFLPGPEESGR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C60H91N17O22
ANDCHIKMTWYV
EG
1402.48
3.96
1
3
2
-2
2.58
-1.315
30.00
Mammalian: 1 hour Yeast: 30 min E.coli: >10 hour
0
0.00
2
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
3
E
1
Q
3
G
0
H
0
I
1
L
0
K
0
M
1
F
2
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 3 Q: 1 G: 3 H: 0 I: 0 L: 1 K: 0 M: 0 F: 1 P: 2 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
13 reviewed residue count
C60H91N17O22 sequence-only estimate (linear, free termini)
1402.48 sequence-only estimate (linear, free termini)
3.96 sequence-only estimate (linear, free termini)
-2 sequence-only estimate (linear, free termini)
2.58 sequence-only estimate (linear, free termini)
-1.315 sequence-only estimate (linear, free termini)
1402.4616 Activity
1401.6503 Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50
ACE inhibitors
457.42 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Złotek U., Jakubczyk A., Rybczyńska-Tkaczyk K., Ćwiek P., Baraniak B., Lewicki S.
Characteristics of new peptides GQLGEHGGAGMG, GEHGGAGMGGGQFQPV, EQGFLPGPEESGR, RLARAGLAQ, YGNPVGGVGH, and GNPVGGVGHGTTGT as inhibitors of enzymes involved in metabolic syndrome and antimicrobial potential. Molecules, 25, 2492, 2020
2020
Journal

Other

13
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)NCC(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N1[C@@]([H])(CCC1)C(=O)NCC(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)O InChI=1S/C60H91N17O22/c1-31(2)25-39(74-55(94)38(26-32-9-4-3-5-10-32)70-45(81)28-66-51(90)34(15-18-43(62)79)71-50(89)33(61)14-19-47(83)84)58(97)77-24-8-12-41(77)56(95)68-29-46(82)76-23-7-13-42(76)57(96)73-36(17-21-49(87)88)53(92)72-35(16-20-48(85)86)54(93)75-40(30-78)52(91)67-27-44(80)69-37(59(98)99)11-6-22-65-60(63)64/h3-5,9-10,31,33-42,78H,6-8,11-30,61H2,1-2H3,(H2,62,79)(H,66,90)(H,67,91)(H,68,95)(H,69,80)(H,70,81)(H,71,89)(H,72,92)(H,73,96)(H,74,94)(H,75,93)(H,83,84)(H,85,86)(H,87,88)(H,98,99)(H4,63,64,65)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1 InChIKey=CHJAORMWSLOKQH-NUDUWCFGSA-N Inhibitor of Alpha-amylase (EC 3.2.1.1) according to the BIOPEP-UWM database of bioactive peptides (ID 9796) Inhibitor of pancreatic lipase according to the BIOPEP-UWM database of bioactive peptides (ID 9797) Inhibitor of lipoxygenase (LOX) according to the BIOPEP-UWM database of bioactive peptides (ID 9798) Inhibitor of cyclooxygenase-1 (EC 1.14.99.1) (COX 1) according to the BIOPEP-UWM database of bioactive peptides (ID 9799) Inhibitor of cyclooxygenase-2 (EC 1.14.99.1) (COX 2) according to the BIOPEP-UWM database of bioactive peptides (ID 9800)
Additional Detail Fields 1 fields
13